Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Aluminum Allergy”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Not applicableStudy completedNCT06130462
What this trial is testing

Detection of Aluminium-reactive T-lymphocytes in Patients With Vaccination Granulomas

Who this might be right for
GranulomaAluminum Allergy
National Allergy Research Center, Denmark 16
Not applicableStudy completedNCT04438135
What this trial is testing

Children With Aluminium Contact Allergy: Cutaneous Exposure Study

Who this might be right for
Contact DermatitisContact AllergyAluminum Allergy
National Allergy Research Center, Denmark 15
Not applicableStudy completedNCT04921163
What this trial is testing

Children With Aluminium Contact Allergy: Oral Exposure Study

Who this might be right for
Contact DermatitisContact AllergyAluminum Allergy
National Allergy Research Center, Denmark 15
Large-scale testing (Phase 3)Study completedNCT00554983
What this trial is testing

Efficacy and Safety From a Recombinant Folding Variant of Bet v 1

Who this might be right for
Allergy
Allergopharma GmbH & Co. KG 255
Testing effectiveness (Phase 2)Study completedNCT00841516
What this trial is testing

Immunological and Histological Evaluation of Specific Immunotherapy With Recombinant Hypoallergenic Derivative

Who this might be right for
Allergic Rhinoconjunctivitis
Allergopharma GmbH & Co. KG 14
Large-scale testing (Phase 3)Study completedNCT00309062
What this trial is testing

Safety and Efficacy of Recombinant Birch Pollen Allergen in the Treatment of Allergic Rhinoconjunctivitis

Who this might be right for
Birch Pollen Allergy
Allergopharma GmbH & Co. KG
Large-scale testing (Phase 3)Study completedNCT00263627
What this trial is testing

Safety and Efficacy of Specific Immunotherapy With an Aluminium Hydroxide-adsorbed Allergoid Preparation of Birch Pollen Allergens

Who this might be right for
Pollen Allergy
Allergopharma GmbH & Co. KG 253
Testing effectiveness (Phase 2)Study completedNCT00266526
What this trial is testing

Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FV

Who this might be right for
Birch Pollen Allergy
Allergopharma GmbH & Co. KG
Not applicableLooking for participantsNCT06529913
What this trial is testing

Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases

Who this might be right for
Allergic Contact DermatitisMetal AllergyFood Allergy+13 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 280
Large-scale testing (Phase 3)Study completedNCT00671268
What this trial is testing

Evaluation of Safety and Efficacy of Specific Immunotherapy With Recombinant Major Allergens of Timothy Grass Pollen Adsorbed Onto Aluminium-hydroxide in Patients With IgE-mediated Allergic Rhinoconjunctivitis +/- Controlled Asthma

Who this might be right for
Rhinoconjunctivitis
Allergopharma GmbH & Co. KG 256
Large-scale testing (Phase 3)Study completedNCT00309036
What this trial is testing

Safety and Efficacy of Recombinant Grass Pollen Allergen Cocktail in the Treatment of Allergic Rhinoconjunctivitis

Who this might be right for
Allergy
Allergopharma GmbH & Co. KG
Testing effectiveness (Phase 2)Study completedNCT02028208
What this trial is testing

Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study

Who this might be right for
Contact Dermatitis
Allerderm 56
Testing effectiveness (Phase 2)Study completedNCT00666341
What this trial is testing

Dose-Response-Study With a Recombinant Cocktail of Phleum (rPhleum) Allergens

Who this might be right for
Type I-Allergy
Allergopharma GmbH & Co. KG 50